VACSAF Trademark

Trademark Overview


On Friday, October 27, 2017, a trademark application was filed for VACSAF with the United States Patent and Trademark Office. The USPTO has given the VACSAF trademark a serial number of 79221183. The federal status of this trademark filing is REGISTERED as of Tuesday, January 15, 2019. This trademark is owned by SISAF Ltd. The VACSAF trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Antiviral pharmaceutical preparations, anti-infective pharmaceutical preparations, anti-inflammatory pharmaceutical preparations, antiseptic pharmaceutical preparations, antibacterial pharmaceutical preparations, antibiotic pharmaceutical preparations, antifungal pharmaceutical preparations, and anti-fibrotic pharmaceutical preparations; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, pulmonary diseases and disorders, immune system related diseases and disorders, hematological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, gastro-intestinal diseases, eye diseases and conditions, heart rhythm disorders, kidney diseases, nephropathic diseases, hematological disorders, diabetes, hypertension, skin disorders, damaged skin and tissue, w...

Chemicals and chemical preparations for use in industry, science and research; Biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and pharmaceutical preparations for topical use; Chemical preparations for pharmaceutical, medical and veterinary research in the nature of reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Silicon for use in industry, science and research; Silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Porous silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Chemical materials, namely, chemical catalysts for carrying and delivery of chemica...
vacsaf

General Information


Serial Number79221183
Word MarkVACSAF
Filing DateFriday, October 27, 2017
Status700 - REGISTERED
Status DateTuesday, January 15, 2019
Registration Number5651894
Registration DateTuesday, January 15, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations, anti-infective pharmaceutical preparations, anti-inflammatory pharmaceutical preparations, antiseptic pharmaceutical preparations, antibacterial pharmaceutical preparations, antibiotic pharmaceutical preparations, antifungal pharmaceutical preparations, and anti-fibrotic pharmaceutical preparations; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, inflammatory diseases and disorders, respiratory diseases and disorders, pulmonary diseases and disorders, immune system related diseases and disorders, hematological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, gastro-intestinal diseases, eye diseases and conditions, heart rhythm disorders, kidney diseases, nephropathic diseases, hematological disorders, diabetes, hypertension, skin disorders, damaged skin and tissue, wrinkles, wounds and allergies, insect bites, dermatological diseases and disorders, HIV, cancer and tumors, bone diseases, arthritis, cardiopulmonary diseases and disorders, infectious diseases, blood disorders, pain, sepsis, alopecia, obesity, cognitive disorders and diseases, neurological disorders, hormonal disorders, disorders of the autoimmune system, metabolic system diseases and disorders, endocrine system diseases and disorders, genitourinary system diseases and disorders; Preparations in the nature of animal feed supplements containing trace elements; Preparations in the nature of human vaccine preparations containing trace elements; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, nutraceutical and veterinary products; Drug delivery agents consisting of nanoparticle compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; Drug delivery agents consisting of silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; Drug delivery agents consisting of porous silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of compounds for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds containing silicon-based nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds containing silicon-based porous nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical vaccines; Drug delivery agents consisting of compounds for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; drug delivery agents consisting of compounds containing silicon-based nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; drug delivery agents consisting of compounds containing silicon-based porous nanoparticles for facilitating the delivery of chemical, biochemical, biological, and pharmaceutical antibiotics; Chemical, biochemical, biological and pharmaceutical substances for medicinal use being pharmaceutical preparation stabilizers
Pseudo MarkVAC SAF; VACCINE SAFE
Goods and ServicesChemicals and chemical preparations for use in industry, science and research; Biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and pharmaceutical preparations for topical use; Chemical preparations for pharmaceutical, medical and veterinary research in the nature of reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; Silicon for use in industry, science and research; Silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Porous silicon nanoparticle materials, namely, silicon and silicon-based chemical compounds for use in industry, science and research; Chemical materials, namely, chemical catalysts for carrying and delivery of chemical, biochemical and biological substances for use in industry and not for medical or veterinary use; Silicon for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Nanoparticle materials, namely, silicon-based chemical compounds for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Silicon nanoparticle materials being silicon-based chemical compounds for use in stabilising enzymes of chemical, biochemical and biological substances for scientific research purposes; Porous silicon nanoparticle materials being silicon-based chemical compounds for stabilising enzymes of chemical, biochemical and biological substances for use in industry and for scientific research purposes; Chemicals and chemical preparations, namely, reagents and catalysts for pharmaceutical research purposes; Chemicals and chemical preparations, namely, reagents and catalysts for scientific research in the field of medicine, veterinary and pharmaceutics; Excipient for use in the manufacture of pharmaceutical products, including for the manufacture of vaccines and veterinary preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, November 25, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSISAF Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBelfast Co. Antrim BT3 9DT
GB

Party NameSISAF Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBelfast Co. Antrim BT3 9DT
GB

Party NameSISAF Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBelfast Co. Antrim BT3 9DT
GB

Trademark Events


Event DateEvent Description
Monday, January 15, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 17, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 1, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 30, 2019FINAL DISPOSITION PROCESSED
Monday, April 15, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Friday, December 14, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Friday, October 26, 2018NOTIFICATION PROCESSED BY IB
Wednesday, October 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 18, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, September 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 18, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, September 18, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, August 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 30, 2018ASSIGNED TO LIE
Wednesday, August 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 9, 2018REFUSAL PROCESSED BY IB
Friday, February 16, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 16, 2018REFUSAL PROCESSED BY MPU
Tuesday, February 13, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 12, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 6, 2018ASSIGNED TO EXAMINER
Wednesday, November 29, 2017APPLICATION FILING RECEIPT MAILED
Saturday, November 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 16, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB